Results 231 to 240 of about 143,588 (347)

New partners for BRCA1 [PDF]

Nature Structural & Molecular Biology, 2007
openaire   +2 more sources

Ewing sarcoma fusion oncogene: At the crossroads of transcription and DNA damage response

Molecular & Cellular Oncology, 2018
Aparna Gorthi, Alexander J. R. Bishop
doaj   +1 more source

Rare <i>BRCA1</i> c.3418_3419insTGACTACT:p.S1140Mfs*18 germline mutation in a family with breast and ovarian cancer. [PDF]

Oncol Lett
Zhai C, Jia L, Wang C, Chen L, Han T, Xiao D.   +5 more
europepmc   +1 more source

Oestrogen receptor phosphorylation profiles and in silico PAM50 subtyping reflect sexual dimorphism in breast cancer

The Journal of Pathology: Clinical Research, Volume 12, Issue 4, July 2026.
Abstract Breast cancer (BC) is most prevalent in females but also accounts for <1% of male cancer cases and 0.2% of male cancer‐related deaths. Distribution of histological subtypes, receptor status, and age of diagnosis varies based on sex, and a growing body of evidence supports sex‐specific molecular differences in BC.
Subarnarekha Chatterji, Aimee Diack, Marcin Szostok, Michael D Morgan, Valentina Silvestri, Laura Ottini, Cathy B Moelans, Paul J van Diest, Cigdem Selli, Andrew H Sims, Rasha Abu‐Eid, Valerie Speirs   +11 more
wiley   +1 more source

Comprehensive <i>BRCA1/2</i> mutation landscape in prostate cancer in the UAE and Arab population. [PDF]

Front Cell Dev Biol
Al Shareef ZM, Al-Shahrabi RM, Bhamidimarri PM, Yener B, Bouzid A, Hamad AM, Murad S, Elbarkouky A, Saheb Sharif-Askari F, Bendardaf R, Hamoudi RA, Hachim MY.   +11 more
europepmc   +1 more source

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines

FEBS Open Bio, Volume 16, Issue 7, Page 1370-1386, July 2026.
Talazoparib is the most potent inducer of senescence among different PARP1 inhibitors in human NSCLC cells. In the absence of PARP, no senescence phenotype was observed, demonstrating that PARP1 is necessary for the induction of senescence by this inhibitor.
Camille Huart, Manon Van den Abbeel, Christoph Schifflers, Karim Bouhjar, Andrea Scarmelotto, Alexis Khelfi, Anne‐Catherine Wera, Carine Michiels   +7 more
wiley   +1 more source

Breaking down BRCA1 [PDF]

Nature Genetics, 1994
openaire   +2 more sources

Restoration of Replication Fork Stability in BRCA1- and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers.

Molecules and Cells, 2017
A. Taglialatela, Silvia Alvarez, G. Leuzzi, V. Sannino, Lepakshi Ranjha, Jen-Wei Huang, Chioma J Madubata, Roopesh Anand, B. Levy, R. Rabadán, Petr Cejka, V. Costanzo, Alberto Ciccia   +12 more
semanticscholar   +1 more source

Higher Levels of <i>BRCA1</i> Gene Methylation in Sporadic Breast Cancer Patients with a Lower Incidence of Recurrence. [PDF]

Med Sci (Basel)
Agnes G, Damin APS, Watte G, Guimarães GR, Roehe AV, Saffi J.   +5 more
europepmc   +1 more source

Cervical Metastasis From Primary Breast Carcinoma: A Case Report and Review of Extragenital Tumors Involving the Uterine Cervix

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Cervical metastases from breast carcinoma should be considered in the differential diagnosis of uterine lesions in patients with prior breast cancer. Re‐biopsy is essential to detect receptor discordance (ER/PR up to 29%) and guide therapy. GCDFP‐15, mammaglobin, and GATA3 confirm mammary origin.
Mario Assenza, Adele Zappalà, Armando Nallbani, Jacopo Wabersich   +3 more
wiley   +1 more source